glp 1 and marathon training Is It Safe to Run While on GLP-1 Meds? Our Experts Explain Done Done Fitness | The

2021 Dec 30;30(4):320-325

Phase 2 Side-Effect Frequencies at 4.5 mg/week (Lancet 2021) Side Effect Nausea Incidence at 4.5 mg/week 47% Side Effect Injection-site reactions Incidence at 4.5 mg/week 43% Side Effect Constipation Incidence at 4.5 mg/week 21% Side Effect Fatigue Incidence at 4.5 mg/week 20% Side Effect Allergic reactions (any) Incidence at 4.5 mg/week 10% Side Effect Vomiting Incidence at 4.5 mg/week 8% Side Effect Loose stools Incidence at 4.5 mg/week 7% Side Effect Headache Incidence at 4.5 mg/week 7% Side Effect Indigestion Incidence at 4.5 mg/week 4% Incidence was lower at lower doses

2021;22:53 Sheng G, Chen P, Wei Y, Yue H, Chu J, Zhao J, et al

Both sorafenib and sulfasalazine are FDA-approved drugs that are efficient ferroptosis activators known to inhibit tumor growth